A recently published study led by John Kirwan, the new executive director of the University of Oklahoma Health Harold Hamm Diabetes Center, identified a protein that may contribute to insulin resistance. Kirwan said the protein, known as Miro1, could be a target for future treatments to help the body regulate blood sugar.
Kirwan joined the center in September after serving eight years as executive director at the Pennington Biomedical Research Center at Louisiana State University. Before that, he spent about 20 years at the Cleveland Clinic, where he founded and directed the Metabolic Translational Research Center.
The translational scientist traveled 632 miles from the life he built in Louisiana to Oklahoma because he saw an opportunity to create impact in a state where, in 2024, 13.2% of adults had been diagnosed with diabetes…